1. Academic Validation
  2. Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cells

Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cells

  • Nanoscale Adv. 2025 Sep 23;7(22):7226-7238. doi: 10.1039/d5na00606f.
Valeria Jose Boide-Trujillo 1 Vincent Mittelheisser 2 Fei Liu 1 3 Olivier Lefebvre 2 Bohdan Andreiuk 1 Nicolas Anton 3 Jacky G Goetz 2 Andrey S Klymchenko 1
Affiliations

Affiliations

  • 1 Laboratoire de Bioimagerie et Pathologies, CNRS UMR_7021, ITI SysChem-Chimie des Systèmes Complexes, Université de Strasbourg Illkirch France [email protected].
  • 2 Tumor Biomechanics Lab, INSERM UMR_S1109, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, Equipe labélisée Ligue Nationale Contre le Cancer Strasbourg France [email protected] https://www.goetzlab.fr.
  • 3 Regenerative Nanomedicine (RNM), INSERM UMR_1260, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg Strasbourg France.
Abstract

Lipid nanoemulsions (NEs) are promising green nanocarriers for diagnostic and therapeutic applications, but their functionalization with biomolecules, such as antibodies, remains a challenge due to liquid nature of their core. Here, we developed an original plug-and-play strategy to graft an antibody (trastuzumab) at the surface of NEs, using components generally recognized as safe (GRAS). We synthesized a reactive 4-nitrophenyl carbonate of Cholesterol (NPC-Chol) and a Biotin-PEG3000-Lysine linker, which can react within one-pot formulation to form an amphiphilic carbamate Biotin-PEG3000-Cholesterol. The Cholesterol ensures anchorage of the linker, which effectively exposes biotin moiety at the surface of NEs for further antibody grafting using a biotin-neutravidin coupling. The reaction between the Biotin-PEG3000-Lysine linker and NPC-Chol was confirmed by 1H-NMR and absorption spectroscopy. The obtained biotinylated 50-nm NEs loaded with a near-infrared dye were successfully targeted to neutravidin-coated glass surfaces and imaged at the single-droplet level. The biotinylated NEs bearing the trastuzumab antibody targeted specifically HER2-amplified breast Cancer models HCC-1954 and SKBR3, in contrast to control MDA-MB-231 (HER2-low) cells. Altogether, our study proposes an efficient methodology for grafting antibodies to the surface of NEs, which offers new opportunities of application of these green nanocarriers in biomedicine.

Figures
Products